Navalign »

Cue Biopharma shares owned by Navalign

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Navalign from 13F filings

Historical chart of Navalign investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Navalign consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Navalign

Quarter filed Position value Share count Share price at filing
2024-03-31 $47k 25k 1.89
2023-12-31 $66k 25k 2.64

More positions owned by Navalign

Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Core S&p Scp Etf (IJR)
Apple (AAPL)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Flexshares Tr Mornstar Upstr (GUNR)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)
Vanguard Index Fds Real Estate Etf (VNQ)
Amgen (AMGN)
Ishares Tr Calif Mun Bd Etf (CMF)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)

View all positions for Navalign

Top funds holding Cue Biopharma

Vanguard Group
BlackRock
Bleichroeder
Geode Capital Management
Robertson Stephens Wealth Management
Dimensional Fund Advisors
Northern Trust
Millennium Management
Monaco Asset Management SAM
Sigma Planning
Bank of America Corporation
GSA Capital Partners
Stifel Financial
Citadel Advisors
Morgan Stanley

View all funds holding Cue Biopharma